{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:47:57Z","timestamp":1792198077022,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02913-5","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T03:03:07Z","timestamp":1750474987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global research trends on Chinese patent drugs inducing programmed cell death in cancer: a bibliometric analysis (1998\u20132024)"],"prefix":"10.1007","volume":"16","author":[{"given":"Min","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"5","key":"2913_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25(5):379\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2913_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/03009858211005537","volume":"58","author":"SF Santagostino","year":"2021","unstructured":"Santagostino SF, Assenmacher CA, Tarrant JC, et al. Mechanisms of regulated cell death: current perspectives. Vet Pathol. 2021;58(4):596\u2013623.","journal-title":"Vet Pathol"},{"key":"2913_CR3","doi-asserted-by":"publisher","first-page":"847345","DOI":"10.3389\/fimmu.2022.847345","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Hong M, Li Y, et al. Programmed cell death tunes tumor immunity. Front Immunol. 2022;13:847345.","journal-title":"Front Immunol"},{"issue":"7","key":"2913_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10495-021-01682-0","volume":"26","author":"X Dai","year":"2021","unstructured":"Dai X, Wang D, Zhang J. Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis. 2021;26(7):385\u2013414.","journal-title":"Apoptosis"},{"issue":"6","key":"2913_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.joim.2021.08.004","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Liang Q, Sun G. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: a focus on epithelial-mesenchymal transition. J Integr Med. 2021;19(6):469\u201377.","journal-title":"J Integr Med"},{"key":"2913_CR6","doi-asserted-by":"publisher","first-page":"609705","DOI":"10.3389\/fimmu.2020.609705","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Lou Y, Wang J, et al. Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment. Front Immunol. 2021;11:609705.","journal-title":"Front Immunol"},{"issue":"1","key":"2913_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13020-023-00719-7","volume":"18","author":"JF Chen","year":"2023","unstructured":"Chen JF, Wu SW, Shi ZM, et al. Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action. Chin Med. 2023;18(1):14.","journal-title":"Chin Med"},{"key":"2913_CR8","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, et al. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170:105728.","journal-title":"Pharmacol Res"},{"issue":"9","key":"2913_CR9","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1039\/D0NP00057D","volume":"38","author":"C Yao","year":"2021","unstructured":"Yao C, Zhang J, Li J, et al. Traditional Chinese medicine (TCM) as a source of new anticancer drugs. Nat Prod Rep. 2021;38(9):1618\u201333.","journal-title":"Nat Prod Rep"},{"key":"2913_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-021-00539-7","volume":"16","author":"H Jiang","year":"2021","unstructured":"Jiang H, Li M, Du K, et al. Traditional Chinese medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction. Chin Med. 2021;16:1\u201320.","journal-title":"Chin Med"},{"issue":"1","key":"2913_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00210-024-03310-5","volume":"398","author":"Y Tang","year":"2025","unstructured":"Tang Y, Xian Z, Wu F, et al. Traditional Chinese medicine combined with chemotherapy in the treatment of advanced non-small cell lung cancer: key drug screening and mechanism analysis. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(1):843\u201354.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2913_CR12","doi-asserted-by":"publisher","first-page":"115748","DOI":"10.1016\/j.jep.2022.115748","volume":"300","author":"Z Wei","year":"2023","unstructured":"Wei Z, Chen J, Zuo F, et al. Traditional Chinese medicine has great potential as candidate drugs for lung cancer: A review. J Ethnopharmacol. 2023;300:115748.","journal-title":"J Ethnopharmacol"},{"key":"2913_CR13","doi-asserted-by":"publisher","first-page":"113249","DOI":"10.1016\/j.jep.2020.113249","volume":"264","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zhang Q, Yu L, et al. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer. J Ethnopharmacol. 2021;264:113249.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2913_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/ijmm.2021.4846","volume":"47","author":"T Chen","year":"2021","unstructured":"Chen T, Yang P, Jia Y. Molecular mechanisms of astragaloside-IV in cancer therapy. Int J Mol Med. 2021;47(3):13.","journal-title":"Int J Mol Med"},{"key":"2913_CR15","doi-asserted-by":"publisher","first-page":"113978","DOI":"10.1016\/j.jep.2021.113978","volume":"274","author":"X Deng","year":"2021","unstructured":"Deng X, Jiao YN, Hao HF, et al. Taraxacum Mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10\/STAT3\/PD-L1 signaling pathways. J Ethnopharmacol. 2021;274:113978.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"2913_CR16","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/ptr.7738","volume":"37","author":"Y Yang","year":"2023","unstructured":"Yang Y, Chen Y, Wu JH, et al. Targeting regulated cell death with plant natural compounds for cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death, and necroptosis. Phytother Res. 2023;37(4):1488\u2013525.","journal-title":"Phytother Res"},{"key":"2913_CR17","doi-asserted-by":"publisher","first-page":"1548672","DOI":"10.3389\/fphar.2025.1548672","volume":"16","author":"S Sun","year":"2025","unstructured":"Sun S, Yu W, Zhang G, et al. Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy. Front Pharmacol. 2025;16:1548672.","journal-title":"Front Pharmacol"},{"key":"2913_CR18","doi-asserted-by":"publisher","first-page":"1033129","DOI":"10.3389\/fnut.2022.1033129","volume":"9","author":"Q Wu","year":"2022","unstructured":"Wu Q, Chen Z, Ding Y, et al. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis. Front Nutr. 2022;9:1033129.","journal-title":"Front Nutr"},{"key":"2913_CR19","doi-asserted-by":"publisher","first-page":"154943","DOI":"10.1016\/j.phymed.2023.154943","volume":"118","author":"X Liu","year":"2023","unstructured":"Liu X, Liu L, Wang X, et al. Necroptosis inhibits autophagy by regulating the formation of RIP3\/p62\/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer. Phytomedicine. 2023;118:154943.","journal-title":"Phytomedicine"},{"issue":"1","key":"2913_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","volume":"24","author":"Z Xi","year":"2025","unstructured":"Xi Z, Dai R, Ze Y, et al. Traditional Chinese medicine in lung cancer treatment. Mol Cancer. 2025;24(1):57.","journal-title":"Mol Cancer"},{"issue":"12","key":"2913_CR21","first-page":"1934578X2312204","volume":"18","author":"W Peng","year":"2023","unstructured":"Peng W, Yang R, Li K, et al. The curative and preventative effects of traditional Chinese medicine on ferroptosis of hepatocellular carcinoma. Nat Prod Commun. 2023;18(12):1934578X231220485.","journal-title":"Nat Prod Commun"},{"issue":"9","key":"2913_CR22","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1002\/mco2.693","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang S, Guo S, Guo J, et al. Cell death pathways: molecular mechanisms and therapeutic targets for cancer. MedComm. 2024;5(9):e693.","journal-title":"MedComm"},{"key":"2913_CR23","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.neo.2024.101017","volume":"55","author":"B Fu","year":"2024","unstructured":"Fu B, Lou YM, Wu P, et al. Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: new dawn for overcoming therapy resistance. Neoplasia. 2024;55:101017.","journal-title":"Neoplasia"},{"key":"2913_CR24","doi-asserted-by":"crossref","unstructured":"He, Guangfeng et al. \u201cSingle-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia.\u201d Frontiers in immunology vol. 15 1494106. 16 Dec. 2024, doi:10.3389\/fimmu.2024.1494106","DOI":"10.3389\/fimmu.2024.1494106"},{"key":"2913_CR25","doi-asserted-by":"publisher","first-page":"1280779","DOI":"10.3389\/fphar.2024.1280779","volume":"15","author":"Y Tang","year":"2024","unstructured":"Tang Y, Zhuang Y, Zhao C, et al. The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy. Front Pharmacol. 2024;15:1280779.","journal-title":"Front Pharmacol"},{"key":"2913_CR26","doi-asserted-by":"crossref","unstructured":"Li Y, Lin H, Sun Y, et al. Platycodin D2 mediates incomplete autophagy and ferroptosis in breast Cancer cells by regulating mitochondrial ROS. Phytotherapy Research; 2024.","DOI":"10.1002\/ptr.8386"},{"key":"2913_CR27","doi-asserted-by":"publisher","first-page":"1086368","DOI":"10.3389\/fgene.2023.1086368","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Tao J, Qian R, et al. Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis. Front Genet. 2023;14:1086368.","journal-title":"Front Genet"},{"issue":"6","key":"2913_CR28","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1002\/ptr.7866","volume":"37","author":"Q Hu","year":"2023","unstructured":"Hu Q, Li Z, Li Y, et al. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: recent advances and perspectives. Phytother Res. 2023;37(6):2661\u201392.","journal-title":"Phytother Res"},{"issue":"3","key":"2913_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/0194262X.2021.1991547","volume":"41","author":"JT McAllister","year":"2022","unstructured":"McAllister JT, Lennertz L, Atencio Mojica Z. Mapping a discipline: a guide to using VOSviewer for bibliometric and visual analysis. Sci Technol Libr. 2022;41(3):319\u201348.","journal-title":"Sci Technol Libr"},{"issue":"3","key":"2913_CR30","first-page":"379","volume":"9","author":"AN Iliescu","year":"2021","unstructured":"Iliescu AN. Conceptual atlas of the Knowmad literature: visual mapping with VOSviewer. Manage Dyn Knowl Econ. 2021;9(3):379\u201392.","journal-title":"Manage Dyn Knowl Econ"},{"key":"2913_CR31","first-page":"1","volume":"28","author":"A Dereli","year":"2024","unstructured":"Dereli A. Vosviewer Ile bibliyometrik analiz. Communicata. 2024;28:1\u20137.","journal-title":"Communicata"},{"issue":"3","key":"2913_CR32","first-page":"164","volume":"13","author":"S B\u00fcy\u00fckk\u0131d\u0131k","year":"2022","unstructured":"B\u00fcy\u00fckk\u0131d\u0131k S. A bibliometric analysis: a tutorial for the bibliometrix package in R using IRT literature. J Meas Eval Educ Psychol. 2022;13(3):164\u201393.","journal-title":"J Meas Eval Educ Psychol"},{"issue":"3","key":"2913_CR33","first-page":"681","volume":"13","author":"WA Bhat","year":"2023","unstructured":"Bhat WA, Khan NL, Manzoor A, et al. How to conduct bibliometric analysis using R-studio: a practical guide. Eur Econ Lett (EEL). 2023;13(3):681\u2013700.","journal-title":"Eur Econ Lett (EEL)"},{"key":"2913_CR34","doi-asserted-by":"publisher","first-page":"784822","DOI":"10.3389\/fphar.2021.784822","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Xu L, Wang S, et al. Confirmation of inhibitingTLR4\/MyD88\/NF-\u03baB signalling pathway by Duhuo Jisheng Decoction on osteoarthritis: a network Pharmacology approach-integrated experimental study. Front Pharmacol. 2022;12:784822.","journal-title":"Front Pharmacol"},{"key":"2913_CR35","doi-asserted-by":"crossref","unstructured":"Gu, Yuheng et al. \u201cRevealing the association between East Asian oral microbiome and colorectal cancer through Mendelian randomization and multi-omics analysis.\u201d Frontiers in cellular and infection microbiology vol. 14 1452392. 17 Sep. 2024, doi:10.3389\/fcimb.2024.1452392","DOI":"10.3389\/fcimb.2024.1452392"},{"issue":"5","key":"2913_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Qiu H, Li C, et al. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283\u201398.","journal-title":"Biosci Trends"},{"key":"2913_CR37","doi-asserted-by":"crossref","unstructured":"Xiong, Jingwen et al. \u201cThe two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential.\u201d Discover oncology vol. 15,1 590. 25 Oct. 2024, doi:10.1007\/s12672-024-01464-5","DOI":"10.1007\/s12672-024-01464-5"},{"key":"2913_CR38","first-page":"1","volume":"8","author":"J Wei","year":"2022","unstructured":"Wei J, Liu Z, He J, et al. Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism. Clin Transl Oncol. 2022;8:1\u201312.","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"2913_CR39","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.7150\/ijbs.77720","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang X, Li J, Chen R, et al. Active ingredients from Chinese medicine for combination cancer therapy. Int J Biol Sci. 2023;19(11):3499.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2913_CR40","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/med.21876","volume":"42","author":"Z Zhong","year":"2022","unstructured":"Zhong Z, Vong CT, Chen F, et al. Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: helping to fight against cancer via multiple targets. Med Res Rev. 2022;42(3):1246\u201379.","journal-title":"Med Res Rev"},{"issue":"4","key":"2913_CR41","first-page":"441","volume":"13","author":"CX Liu","year":"2021","unstructured":"Liu CX. Overview on development of ASEAN traditional and herbal medicines. Chin Herb Med. 2021;13(4):441\u201350.","journal-title":"Chin Herb Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02913-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02913-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02913-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:02:44Z","timestamp":1750518164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02913-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02913-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent to Participate declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"thics and Consent to Publish declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1171"}}